rss
Arch Dis Child Fetal Neonatal Ed 93:F151-F152 doi:10.1136/adc.2006.115162
  • Case report

Pyridoxal phosphate-dependent neonatal epileptic encephalopathy

  1. S Bagci1,
  2. J Zschocke2,
  3. G F Hoffmann3,
  4. T Bast4,
  5. J Klepper5,
  6. A Müller1,
  7. A Heep1,
  8. P Bartmann1,
  9. A R Franz1
  1. 1
    Centre for Paediatrics, Department of Neonatology, University of Bonn, Germany
  2. 2
    Institute of Human Genetics, University of Heidelberg, Germany
  3. 3
    Department of General Paediatrics, University of Heidelberg, Germany
  4. 4
    Department of Paediatric Neurology, University of Heidelberg, Germany
  5. 5
    Department of Paediatric Neurology, University of Essen, Germany
  1. Dr A R Franz, Department of Neonatology, Centre for Paediatrics, Sigmund-Freud-Strasse 25, 53105 Bonn, Germany; axel.franz{at}ukb.uni-bonn.de
  • Accepted 2 April 2007

Abstract

Pyridox(am)ine-5′-phosphate oxidase converts pyridoxine phosphate and pyridoxamine phosphate to pyridoxal phosphate, a cofactor in many metabolic reactions, including neurotransmitter synthesis. A family with a mutation in the pyridox(am)ine-5′-phosphate oxidase gene presenting with neonatal seizures unresponsive to pyridoxine and anticonvulsant treatment but responsive to pyridoxal phosphate is described. Pyridoxal phosphate should be considered in neonatal epileptic encephalopathy unresponsive to pyridoxine.

Footnotes

  • Competing interests: None.

Latest from Education & Practice

Latest from Education & Practice

Register for free content

Free sample
This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of ADC Fetal & Neonatal.
View free sample issue >>

Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.

Navigate This Article